The Transplant Center at Massachusetts General Hospital hosted a virtual event to share the latest updates on COVID-19 and transplantation. A panel of experts COVID-19’s impact on transplantation—from vaccine recommendations, use of monoclonal antibody therapy, what to do when symptomatic or positive, and traveling during the pandemic.

Panelists:
Emily Bethea, MD, medical director, Liver Transplant Program
Nahel Elias, MD, surgical director, Kidney Transplantation Quality Improvement Chair
Brian Keller, MD, PhD, medical director, Lung Transplant Program
Camille Kotton, MD, FIDSA, FAST, clinical director, Transplant and Immunocompromised Host Infectious Diseases
Gregory Lewis, MD, medical director, Heart Transplant Program
Leonardo Riella, MD, PhD, medical director, Kidney Transplant Program

The Transplant Center offers leading-edge consultative services, treatment and surgical interventions to patients with a broad spectrum of diseases requiring heart, lung, kidney, liver, pancreas, islet, hematopoietic stem cell and multiple organ transplants. Learn more: [ Ссылка ]

свернуть